Same Indication

Metformin vs Pembrolizumab

Metformin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Metformin and Pembrolizumab.

Mechanism of Action

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Metformin — 4-9 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Metformin — C4H11N5.

Molecular Weight: Metformin — 129.1640 g/mol.

Type: Metformin — Small molecule; Pembrolizumab — Antibody.